Sanchez Ramiro

Sanchez Ramiro is listed in filings as Director at Alto Neuroscience, Inc.. This profile follows SEC Form 4 activity through May 14, 2026, including 9 public disclosures. Recent filings connect the profile to Alto Neuroscience, Inc. (ANRO), Rapport Therapeutics, Inc. Common Stock (RAPP), and Cerevel Therapeutics Holdings, Inc. (CERE). The current snapshot covers public activity from Aug 5, 2024 to May 14, 2026. Reported amounts are shown as $269.9K to $97.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.